Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study.
cancer incidence
cancer mortality
cohort study
lifetime risk
smoking
tobacco
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
revised:
01
04
2021
received:
14
12
2020
accepted:
29
04
2021
pubmed:
21
5
2021
medline:
7
9
2021
entrez:
20
5
2021
Statut:
ppublish
Résumé
Tobacco smoke is a known carcinogen, but the magnitude of smoking-related cancer risk depends on country-specific, generational smoking patterns. We quantified cancer risk in relation to smoking in a population-based cohort, the 45 and Up Study (2006-2009) in New South Wales, Australia. Cox proportional hazards regressions estimated adjusted hazard ratios (HR) by self-reported smoking history at baseline (2006-2009) for incident, primary cancers via linkage to cancer registry data to 2013 and cancer death data to 2015. Among 229 028 participants aged ≥45 years, 18 475 cancers and 5382 cancer deaths occurred. Current-smokers had increased risks of all cancers combined (HR = 1.42, 95% confidence interval [CI], 1.34-1.51), cancers of the lung (HR = 17.66, 95%CI, 14.65-21.29), larynx (HR = 11.29, 95%CI, 5.49-23.20), head-and-neck (HR = 2.53, 95%CI, 1.87-3.41), oesophagus (HR = 3.84, 95%CI, 2.33-6.35), liver (HR = 4.07, 95%CI, 2.55-6.51), bladder (HR = 3.08, 95%CI, 2.00-4.73), pancreas (HR = 2.68, 95%CI, 1.93-3.71), colorectum (HR = 1.31, 95%CI, 1.09-1.57) and unknown primary site (HR = 3.26, 95%CI, 2.19-4.84) versus never-smokers. Hazards increased with increasing smoking intensity; compared to never-smokers, lung cancer HR = 9.22 (95%CI, 5.14-16.55) for 1-5 cigarettes/day and 38.61 (95%CI, 25.65-58.13) for >35 cigarettes/day. Lung cancer risk was lower with quitting at any age but remained higher than never-smokers for quitters aged >25y. By age 80y, an estimated 48.3% of current-smokers (41.1% never-smokers) will develop cancer, and 14% will develop lung cancer, including 7.7% currently smoking 1-5 cigarettes/day and 26.4% for >35 cigarettes/day (1.0% never-smokers). Cancer risk for Australian smokers is significant, even for 'light' smokers. These contemporary estimates underpin the need for continued investment in strategies to prevent smoking uptake and facilitate cessation, which remain key to reducing cancer morbidity and mortality worldwide.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1076-1088Informations de copyright
© 2021 UICC.
Références
International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal Habits and Indoor Combustions. Volume 100E A Review of Human Carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 100E; 2012.
Wenbin D, Zhuo C, Zhibing M, et al. The effect of smoking on the risk of gallbladder cancer: a meta-analysis of observational studies. Eur J Gastroenterol Hepatol. 2013;25:373-379. https://doi.org/10.1097/meg.0b013e32835a870b.
Kaaks R, Sookthai D, Hemminki K, et al. Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort. Int J Cancer. 2014;135:2475-2481. https://doi.org/10.1002/ijc.28874.
Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368:351-364. https://doi.org/10.1056/nejmsa1211127.
Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tobacco Control. 2012;21:96-101. https://doi.org/10.1136/tobaccocontrol-2011-050294.
Scollo MM, Winstanley M. Tobacco in Australia: Facts and Issues; 2019. http://www.tobaccoinaustralia.org.au. Accessed May 24, 2021.
Australian Institute of Health and Welfare. National Drug Strategy Household Survey; 2019. https://www.aihw.gov.au/reports/illicit-use-of-drugs/national-drug-strategy-household-survey-2019/contents/table-of-contents.
Adair T, Hoy D, Dettrick Z, Lopez AD. Reconstruction of long-term tobacco consumption trends in Australia and their relationship to lung cancer mortality. Cancer Causes Control. 2011;22:1047-1053. https://doi.org/10.1007/s10552-011-9781-0.
Australian Institute of Health and Welfare. Cancer in Australia 2017. Cancer Series No.101. CAT. No. CAN 100; 2017.
Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005;116:963-971. https://doi.org/10.1002/ijc.21100.
Australian Institute of Health and Welfare. Australian Burden of Disease 2011: Methods and Supplementary Material. Australian Burden of Disease Study series No. 5. Cat. No. BOD 6; 2016.
Schane RE, Ling PM, Glantz SA. Health effects of light and intermittent smoking: a review. Circulation. 2010;121:1518-1522. https://doi.org/10.1161/circulationaha.109.904235.
Inoue-Choi M, Hartge P, Liao LM, Caporaso N, Freedman ND. Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort. Int J Cancer. 2018;142:271-280. https://doi.org/10.1002/ijc.31059.
Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovic D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;j5855. https://doi.org/10.1136/bmj.j5855.
Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, et al. The effect of occasional smoking on smoking-related cancers: in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2006;17:1305-1309. https://doi.org/10.1007/s10552-006-0068-9.
Lopez AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in developed countries. Tobacco Control. 1994;3:242-247.
Banks E, Redman S, Jorm L, et al. Cohort profile: the 45 and up study. Int J Epidemiol. 2008;37:941-947.
Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol. 2010;10:26. https://doi.org/10.1186/1471-2288-10-26.
Jaro MA. Probabilistic linkage of large public health data files. Stat Med. 1995;14:491-498.
CHeReL. Centre for Health Record Linkage; 2020. https://www.cherel.org.au/.
Kelman CW, Bass AJ, Holman CDJ. Research use of linked health data-a best practice protocol. Aust N Z J Public Health. 2002;26:251-255. https://doi.org/10.1111/j.1467-842x.2002.tb00682.x.
Bentley JP, Ford JB, Taylor LK, Irvine KA, Roberts CL. Investigating linkage rates among probabilistically linked birth and hospitalization records. BMC Med Res Methodol. 2012;12:149. https://doi.org/10.1186/1471-2288-12-149.
Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6-10. https://doi.org/10.5694/j.1326-5377.2006.tb00086.x.
Austin PC, Fine JP. Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017;36:4391-4400. https://doi.org/10.1002/sim.7501.
Pirie K, Peto R, Reeves GK, Green J, Beral V. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381:133-141. https://doi.org/10.1016/s0140-6736(12)61720-6.
Freedman ND, Abnet CC, Caporaso NE, et al. Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking-related cancers among the women and men of the NIH-AARP cohort. Int J Epidemiol. 2016;45:846-856. https://doi.org/10.1093/ije/dyv175.
Agudo A, Bonet C, Travier N, et al. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol. 2012;30:4550-4557.
Wang A, Kubo J, Luo J, et al. Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohort. Ann Oncol. 2015;26:221-230. https://doi.org/10.1093/annonc/mdu470.
Australian Bureau of Statistics. National Health Survey: First Results, 2017-2018. Cat No. 4364.0.55.001; 2018.
Lubin JH, Caporaso NE. Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev. 2006;15:517-523. https://doi.org/10.1158/1055-9965.epi-05-0863.
Laaksonen MA, Canfell K, MacInnis R, et al. The future burden of lung cancer attributable to current modifiable behaviours: a pooled study of seven Australian cohorts. Int J Epidemiol. 2018;47:1772-1783.
Vajdic CM, Perez-Concha O, Dobbins T, et al. Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP). Cancer Epidemiol. 2019;60:156-161. https://doi.org/10.1016/j.canep.2019.04.004.
Australian Institute of Health and Welfare. Cancer in Australia 2019; 2019.
Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet. 2012;379:1428-1435. https://doi.org/10.1016/s0140-6736(11)61178-1.
Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease. Br J Cancer. 2002;87:1234-1245.
Gaudet MM, Carter BD, Brinton LA, et al. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies. Int J Epidemiol. 2016;46:881-893. https://doi.org/10.1093/ije/dyw288.
Macacu A, Autier P, Boniol M, Boyle P. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat. 2015;154:213-224. https://doi.org/10.1007/s10549-015-3628-4.
van Osch FHM, Jochems SHJ, van Schooten FJ, Bryan RT, Zeegers MP. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. Int J Epidemiol. 2016;45:857-870. https://doi.org/10.1093/ije/dyw044.
Maasland DHE, van den Brandt PA, Kremer B, Goldbohm RA, Schouten LJ. Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results from the Netherlands Cohort Study. BMC Cancer. 2014;14:187. https://doi.org/10.1186/1471-2407-14-187.
Wang QL, Xie SH, Li WT, Lagergren J. Smoking cessation and risk of esophageal cancer by histological type: systematic review and meta-analysis. J Natl Cancer Inst. 2017;109. https://doi.org/10.1093/jnci/djx115.
Cheng J, Chen Y, Wang XL, et al. Meta-analysis of prospective cohort studies of cigarette smoking and the incidence of colon and rectal cancers. Eur J Cancer Prev. 2015;24:6-15. https://doi.org/10.1097/cej.0000000000000011.
Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta-analysis. Int J Cancer. 2009;124:2406-2415. https://doi.org/10.1002/ijc.24191.
Ben QW, Liu J, Sun YW, Wang LF, Zou DW, Yuan YZ. Cigarette smoking and mortality in patients with pancreatic cancer: a systematic review and meta-analysis. Pancreas. 2019;48:985-995. https://doi.org/10.1097/mpa.0000000000001383.
Lee YC, Cohet C, Yang YC, Stayner L, Hashibe M, Straif K. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol. 2009;38:1497-1511. https://doi.org/10.1093/ije/dyp280.
Melaku YA, Appleton SL, Gill TK, et al. Incidence, prevalence, mortality, disability-adjusted life years and risk factors of cancer in Australia and comparison with OECD countries, 1990-2015: findings from the Global Burden of Disease Study 2015. Cancer Epidemiol. 2018;52:43-54. https://doi.org/10.1016/j.canep.2017.11.007.
Rohrmann S, Linseisen J, Allen N, et al. Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2013;108:708-714. https://doi.org/10.1038/bjc.2012.520.
Li Z, Wang Z, Yu Y, Zhang H, Chen L. Smoking is inversely related to cutaneous malignant melanoma: results of a meta-analysis. Br J Dermatol. 2015;173:1540-1543. https://doi.org/10.1111/bjd.13998.